相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia
Won-Il Kim et al.
BLOOD (2009)
JunB Protects against Myeloid Malignancies by Limiting Hematopoietic Stem Cell Proliferation and Differentiation without Affecting Self-Renewal
Marianne Santaguida et al.
CANCER CELL (2009)
Mouse models of human AML accurately predict chemotherapy response
Johannes Zuber et al.
GENES & DEVELOPMENT (2009)
New insights to the MLL recombinome of acute leukemias
C. Meyer et al.
LEUKEMIA (2009)
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
Naoko Watanabe-Okochi et al.
BLOOD (2008)
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression
Asako Sakaue-Sawano et al.
CELL (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment
M. C. Stubbs et al.
LEUKEMIA (2008)
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Piu Wong et al.
GENES & DEVELOPMENT (2007)
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Guang Jin et al.
BLOOD (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Chaitali Parikh et al.
BLOOD (2006)
Oncogenic K-ras cooperates with PML-RARα to induce an acute promyelocytic leukemia-like disease
Iris T. Chan et al.
BLOOD (2006)
A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy
Weili Chen et al.
BLOOD (2006)
K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements
DC Liang et al.
CANCER (2006)
Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4
R Ono et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia
DH Christiansen et al.
LEUKEMIA (2005)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Continuous MLL-ENL expression is necessary to establish a Hox code and maintain immortalization of hematopoietic progenitor cells
SJ Horton et al.
CANCER RESEARCH (2005)
Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis
LF Drynan et al.
EMBO JOURNAL (2005)
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice
C Schessl et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
C Choudhary et al.
BLOOD (2005)
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model
R Grundler et al.
BLOOD (2005)
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
R Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease
J Wang et al.
EMBO JOURNAL (2005)
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis
A Daser et al.
GENES & DEVELOPMENT (2004)
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy
T Taketani et al.
BLOOD (2004)
Hematopoietic, angiogenic and eye defects in Meis1 mutant animals
T Hisa et al.
EMBO JOURNAL (2004)
MLL: a histone methyltransferase disrupted in leukemia
JL Hess
TRENDS IN MOLECULAR MEDICINE (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor
MC Chillon et al.
HEMATOLOGY JOURNAL (2004)
Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3)
K Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genornics
T Kitamura et al.
EXPERIMENTAL HEMATOLOGY (2003)
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
LM Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
PM Ayton et al.
ONCOGENE (2001)
Constitutive activation of STAT5 by a point mutation in the SH2 domain
K Ariyoshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced Meis expression
KR Calvo et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
J Schwaller et al.
MOLECULAR CELL (2000)
分享论文
